Genpharmasec Ltd. Holds Board Meeting to Approve Q2 Un-audited Financial Results
Genpharmasec Ltd. announced that its Board of Directors will meet on Tuesday, August 11, 2026, to review and approve the company’s un-audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The meeting is scheduled to consider these results along with the Limited Review Report.The Board of Directors will convene at the Company's Registered Office on August 11, 2026, to address the financial performance and other matters as deemed necessary by the board.
In addition to reviewing the quarterly results, Genpharmasec Ltd. specified that the meeting agenda includes considering any other business with the permission of a Chairman.
The company also provided details regarding the trading window for its directors, designated persons, their immediate relatives, and specified connected persons. The insider trading window has been kept closed starting from July 01, 2026. This period of closure will continue until 48 hours after the declaration of the Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
Stock Price Movement
At 12:37, Genpharmasec Ltd shares are slipping, currently valued at ₹1.02, marking a 1.92% decline. The stock has seen significant intraday movement, registering a range that stretched from a low of ₹1.01 to a high of ₹1.04.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.